Package 46708-313-30

{"route": ["ORAL"], "spl_id": "5c2a05ed-ff36-4dce-97e9-77b2d948b4f0", "openfda": {"nui": ["N0000185502", "N0000185501"], "unii": ["1C058IKG3B"], "rxcui": ["1310525", "1310533"], "spl_set_id": ["2b084b44-f15b-4b16-b700-4382434f2136"], "pharm_class_epc": ["Pyrimidine Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Dihydroorotate Dehydrogenase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (46708-313-14)  / 14 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "46708-313-14", "marketing_start_date": "20230125"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (46708-313-30)", "package_ndc": "46708-313-30", "marketing_start_date": "20230125"}], "brand_name": "TERIFLUNOMIDE", "product_id": "46708-313_5c2a05ed-ff36-4dce-97e9-77b2d948b4f0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dihydroorotate Dehydrogenase Inhibitors [MoA]", "Pyrimidine Synthesis Inhibitor [EPC]"], "product_ndc": "46708-313", "generic_name": "TERIFLUNOMIDE", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TERIFLUNOMIDE", "active_ingredients": [{"name": "TERIFLUNOMIDE", "strength": "7 mg/1"}], "application_number": "ANDA209572", "marketing_category": "ANDA", "marketing_start_date": "20230125", "listing_expiration_date": "20261231"}